TPST

Tempest Therapeutics, Inc.CIK 1544227 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for TPST PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for TPST

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Frederick John W.	Director	1	$0	$0	2026-10-13
Smith Nancy Freda	Director	1	$0	$0	2026-09-22
Richey William Drake	Director	1	$0	$0	2026-06-04
Yee John D.	Director	1	$0	$0	2026-06-04
Trojanowski Justin	Principal Accounting Officer	7	$16.2K	$0	2026-03-31
Maestas Nicholas	VP of Strategy and Finance	8	$0	$0	2026-03-31
Angel Matthew	CEO and President	5	$1.00M	$0	2026-03-24
Simantov Ronit	Director	5	$0	$0	2026-01-27
RAAB MICHAEL	Director	8	$0	$0	2026-01-27
NICHOL GEOFFREY	Director	6	$0	$0	2026-01-27
Pellizzari Christine A	Director	6	$0	$0	2026-01-27
Whiting Samuel	Chief Medical Officer	12	$18.1K	$0	2025-01-02
Brady Stephen R	President and CEO	11	$73.8K	$0	2025-01-02
Versant Venture Capital VI, L.P.	10% Owner	2	$0	$966.8K	2024-08-12
Dubensky Thomas W.	President	9	$9.6K	$0	2023-01-03
Lorenzo Pierre	Corporate Controller	6	$0	$0	2022-06-21
Woiwode Thomas	Director, 10% Owner	7	$5.00M	$0	2022-06-17
Xu Stella	Director	3	$0	$0	2021-07-01

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Frederick John W.	Director	A Award deriv	2026-10-13	2026-11-02	25,000	—	$0	25,000	SEC↗
Smith Nancy Freda	Director	A Award deriv	2026-09-22	2026-10-02	25,000	—	$0	25,000	SEC↗
Richey William Drake	Director	A Award deriv	2026-06-04	2026-06-08	25,000	—	$0	25,000	SEC↗
Yee John D.	Director	A Award deriv	2026-06-04	2026-06-17	25,000	—	$0	25,000	SEC↗
Maestas Nicholas	Chief Financial Officer	A Award deriv	2026-03-31	2026-04-02	140,000	—	$0	140,000	SEC↗
Trojanowski Justin	Corporate Controller	A Award deriv	2026-03-31	2026-04-02	22,000	—	$0	22,000	SEC↗
Angel Matthew	CEO and President	P Buy deriv	2026-03-24	2026-06-23	231,482	—	$0	231,482	SEC↗
Angel Matthew	CEO and President	P Buy deriv	2026-03-24	2026-06-23	231,482	—	$0	231,482	SEC↗
Angel Matthew	CEO and President	P Buy	2026-03-24	2026-06-23	231,482	$2.16	$500.0K	231,482	SEC↗
Angel Matthew	CEO and President	P Buy	2026-03-24	2026-03-25	231,482	$2.16	$500.0K	231,482	SEC↗
Angel Matthew	CEO and President	A Award deriv	2026-02-04	2026-02-06	269,621	—	$0	269,621	SEC↗
NICHOL GEOFFREY	Director	A Award deriv	2026-01-27	2026-01-28	1,230	—	$0	1,230	SEC↗
Pellizzari Christine A	Director	A Award deriv	2026-01-27	2026-01-28	1,230	—	$0	1,230	SEC↗
RAAB MICHAEL	Director	A Award deriv	2026-01-27	2026-01-28	1,230	—	$0	1,230	SEC↗
Simantov Ronit	Director	A Award deriv	2026-01-27	2026-01-28	1,230	—	$0	1,230	SEC↗
Maestas Nicholas	Chief Financial Officer	A Award deriv	2025-01-02	2025-01-06	200,000	—	$0	200,000	SEC↗
Whiting Samuel	Chief Medical Officer	A Award deriv	2025-01-02	2025-01-06	270,000	—	$0	270,000	SEC↗
Brady Stephen R	President and CEO	A Award deriv	2025-01-02	2025-01-06	550,000	—	$0	550,000	SEC↗
Trojanowski Justin	Corporate Controller	A Award deriv	2025-01-02	2025-01-06	30,000	—	$0	30,000	SEC↗
Versant Venture Capital VI, L.	10% Owner	S Sale	2024-08-12	2024-08-12	387,999	$1.10	$426.8K	209,941	SEC↗
Versant Venture Capital VI, L.	10% Owner	S Sale	2024-08-08	2024-08-12	400,000	$1.35	$540.0K	597,940	SEC↗
Brady Stephen R	President and CEO	P Buy	2024-07-03	2024-07-08	35,000	$2.11	$73.8K	46,376	SEC↗
Whiting Samuel	Chief Medical Officer	P Buy	2024-07-02	2024-07-03	4,672	$2.13	$10.0K	9,573	SEC↗
Trojanowski Justin	Corporate Controller	P Buy	2024-06-28	2024-07-02	7,500	$2.16	$16.2K	22,168	SEC↗
RAAB MICHAEL	Director	A Award deriv	2024-06-13	2024-06-14	16,000	—	$0	16,000	SEC↗
Simantov Ronit	Director	A Award deriv	2024-06-13	2024-06-14	16,000	—	$0	16,000	SEC↗
NICHOL GEOFFREY	Director	A Award deriv	2024-06-13	2024-06-14	16,000	—	$0	16,000	SEC↗
Pellizzari Christine A	Director	A Award deriv	2024-06-13	2024-06-14	16,000	—	$0	16,000	SEC↗
Maestas Nicholas	VP of Strategy and Finance	A Award deriv	2024-01-03	2024-01-05	40,000	—	$0	40,000	SEC↗
Trojanowski Justin	Principal Accounting Officer	A Award deriv	2024-01-03	2024-01-05	26,500	—	$0	26,500	SEC↗
Whiting Samuel	Chief Medical Officer	A Award deriv	2024-01-03	2024-01-05	100,000	—	$0	100,000	SEC↗
Brady Stephen R	President and CEO	A Award deriv	2024-01-03	2024-01-05	250,000	—	$0	250,000	SEC↗
Maestas Nicholas	VP of Strategy and Finance	A Award deriv	2023-10-11	2023-10-13	100,000	—	$0	100,000	SEC↗
Whiting Samuel	Chief Medical Officer	A Award deriv	2023-10-11	2023-10-13	325,000	—	$0	325,000	SEC↗
Trojanowski Justin	Corporate Controller	A Award deriv	2023-10-11	2023-10-13	55,000	—	$0	55,000	SEC↗
Brady Stephen R	President and CEO	A Award deriv	2023-10-11	2023-10-13	725,000	—	$0	725,000	SEC↗
Simantov Ronit	Director	A Award deriv	2023-06-15	2023-06-20	8,200	—	$0	8,200	SEC↗
Pellizzari Christine A	Director	A Award deriv	2023-06-15	2023-06-20	8,200	—	$0	8,200	SEC↗
NICHOL GEOFFREY	Director	A Award deriv	2023-06-15	2023-06-20	8,200	—	$0	8,200	SEC↗
RAAB MICHAEL	Director	A Award deriv	2023-06-15	2023-06-20	8,200	—	$0	8,200	SEC↗
Trojanowski Justin	Corporate Controller	A Award deriv	2023-01-03	2023-01-05	20,300	—	$0	20,300	SEC↗
Maestas Nicholas	VP of Strategy and Finance	A Award deriv	2023-01-03	2023-01-05	38,425	—	$0	38,425	SEC↗
Brady Stephen R	Chief Executive Officer	A Award deriv	2023-01-03	2023-01-05	177,300	—	$0	177,300	SEC↗
Dubensky Thomas W.	President	A Award deriv	2023-01-03	2023-01-05	102,700	—	$0	102,700	SEC↗
Whiting Samuel	Chief Medical Officer	A Award deriv	2023-01-03	2023-01-05	69,700	—	$0	69,700	SEC↗
Trojanowski Justin	Corporate Controller	A Award deriv	2022-10-03	2022-10-04	2,500	—	$0	2,500	SEC↗
Brady Stephen R	Chief Executive Officer	A Award deriv	2022-06-21	2022-06-22	173,533	—	$0	173,533	SEC↗
Dubensky Thomas W.	President	A Award deriv	2022-06-21	2022-06-22	87,801	—	$0	87,801	SEC↗
Whiting Samuel	Chief Medical Officer	A Award deriv	2022-06-21	2022-06-22	55,680	—	$0	55,680	SEC↗
Maestas Nicholas	VP of Strategy and Finance	A Award deriv	2022-06-21	2022-06-22	51,270	—	$0	51,270	SEC↗
Lorenzo Pierre	Corporate Controller	A Award deriv	2022-06-21	2022-06-22	8,477	—	$0	8,477	SEC↗
RAAB MICHAEL	Director	A Award deriv	2022-06-17	2022-06-22	3,500	—	$0	3,500	SEC↗
Simantov Ronit	Director	A Award deriv	2022-06-17	2022-06-22	3,500	—	$0	3,500	SEC↗
Woiwode Thomas	Director	A Award deriv	2022-06-17	2022-06-22	3,500	—	$0	3,500	SEC↗
NICHOL GEOFFREY	Director	A Award deriv	2022-06-17	2022-06-22	3,500	—	$0	3,500	SEC↗
Pellizzari Christine A	Director	A Award deriv	2022-06-17	2022-06-22	3,500	—	$0	3,500	SEC↗
Woiwode Thomas	Director, 10% Owner	P Buy	2022-04-29	2022-05-03	2,118,644	$2.36	$5.00M	2,118,644	SEC↗
Dubensky Thomas W.	President	P Buy	2022-01-07	2022-01-11	2,000	$4.78	$9.6K	113,343	SEC↗
Whiting Samuel	Chief Medical Officer	P Buy	2022-01-06	2022-01-10	1,700	$4.80	$8.2K	1,901	SEC↗
Dubensky Thomas W.	President	A Award deriv	2022-01-04	2022-01-06	53,100	—	$0	53,100	SEC↗
Brady Stephen R	Chief Executive Officer	A Award deriv	2022-01-04	2022-01-06	94,500	—	$0	94,500	SEC↗
Whiting Samuel	Chief Medical Officer	A Award deriv	2022-01-04	2022-01-06	29,000	—	$0	29,000	SEC↗
Maestas Nicholas	VP of Strategy and Finance	A Award deriv	2022-01-04	2022-01-06	19,500	—	$0	19,500	SEC↗
Lorenzo Pierre	Corporate Controller	A Award deriv	2022-01-04	2022-01-06	6,500	—	$0	6,500	SEC↗
RAAB MICHAEL	Director	A Award deriv	2021-09-21	2021-09-23	6,635	—	$0	6,635	SEC↗
Simantov Ronit	Director	A Award deriv	2021-08-06	2021-08-10	6,635	—	$0	6,635	SEC↗
Maestas Nicholas	VP of Strategy and Finance	A Award deriv	2021-07-12	2021-07-14	23,225	—	$0	23,225	SEC↗
Pellizzari Christine A	Director	A Award deriv	2021-07-01	2021-07-06	6,635	—	$0	6,635	SEC↗
NICHOL GEOFFREY	Director	A Award deriv	2021-07-01	2021-07-06	6,635	—	$0	6,635	SEC↗
Woiwode Thomas	Director, 10% Owner	A Award deriv	2021-07-01	2021-07-06	6,635	—	$0	6,635	SEC↗
Xu Stella	Director	A Award deriv	2021-07-01	2021-07-06	6,635	—	$0	6,635	SEC↗
Xu Stella	Director	A Award deriv	2021-07-01	2021-09-20	6,635	—	$0	6,635	SEC↗
Woiwode Thomas	Director	A Award deriv	2021-07-01	2021-09-20	6,635	—	$0	6,635	SEC↗
Pellizzari Christine A	Director	A Award deriv	2021-07-01	2021-09-20	6,635	—	$0	6,635	SEC↗
NICHOL GEOFFREY	Director	A Award deriv	2021-07-01	2021-09-20	6,635	—	$0	6,635	SEC↗
Lorenzo Pierre	Corporate Controller	A Award deriv	2021-06-25	2021-06-29	1,234	—	$0	1,234	SEC↗
Lorenzo Pierre	Corporate Controller	A Award deriv	2021-06-25	2021-06-29	48,535	—	$0	48,535	SEC↗
Lorenzo Pierre	Corporate Controller	A Award deriv	2021-06-25	2021-06-29	4,830	—	$0	4,830	SEC↗
Brady Stephen R	Chief Executive Officer	A Award deriv	2021-06-25	2021-06-29	1,982,250	—	$0	1,982,250	SEC↗
Brady Stephen R	Chief Executive Officer	A Award deriv	2021-06-25	2021-06-29	110,432	—	$0	110,432	SEC↗
Brady Stephen R	Chief Executive Officer	A Award deriv	2021-06-25	2021-06-29	8,050	—	$0	8,050	SEC↗
Brady Stephen R	Chief Executive Officer	A Award deriv	2021-06-25	2021-06-29	70,256	—	$0	70,256	SEC↗
Dubensky Thomas W.	President	A Award deriv	2021-06-25	2021-06-29	36,263	—	$0	36,263	SEC↗
Dubensky Thomas W.	President	A Award deriv	2021-06-25	2021-06-29	8,050	—	$0	8,050	SEC↗
Dubensky Thomas W.	President	A Award deriv	2021-06-25	2021-06-29	1,000,000	—	$0	1,000,000	SEC↗
Dubensky Thomas W.	President	A Award deriv	2021-06-25	2021-06-29	45,988	—	$0	45,988	SEC↗
RAAB MICHAEL	Director	A Award deriv	2021-06-25	2021-06-29	4,830	—	$0	4,830	SEC↗
RAAB MICHAEL	Director	A Award deriv	2021-06-25	2021-06-29	16,784	—	$0	16,784	SEC↗
RAAB MICHAEL	Director	A Award deriv	2021-06-25	2021-06-29	9,660	—	$0	9,660	SEC↗
Whiting Samuel	Chief Medical Officer	A Award deriv	2021-06-25	2021-06-30	3,018	—	$0	3,018	SEC↗
Whiting Samuel	Chief Medical Officer	A Award deriv	2021-06-25	2021-06-30	61,945	—	$0	61,945	SEC↗
Whiting Samuel	Chief Medical Officer	A Award deriv	2021-06-25	2021-06-30	540,231	—	$0	540,231	SEC↗
Lorenzo Pierre	Corporate Controller	A Award	2021-06-25	2021-06-29	53	—	$0	53	SEC↗
Woiwode Thomas	Director, 10% Owner	A Award	2021-06-25	2021-06-29	997,940	—	$0	997,940	SEC↗
Woiwode Thomas	Director, 10% Owner	A Award	2021-06-25	2021-06-29	1,171,094	—	$0	1,171,094	SEC↗
Woiwode Thomas	Director, 10% Owner	A Award	2021-06-25	2021-06-29	7,377	—	$0	7,377	SEC↗
Dubensky Thomas W.	President	A Award	2021-06-25	2021-06-29	111,343	—	$0	111,343	SEC↗
Xu Stella	Director	A Award	2021-06-25	2021-06-29	579,710	—	$0	579,710	SEC↗
Whiting Samuel	Chief Medical Officer	A Award	2021-06-25	2021-06-30	201	—	$0	201	SEC↗